Answers are grounded in this paper and cite their sources.
In critically ill patients with pulmonary hypertension, dobutamine, milrinone, inhaled nitric oxide, and intravenous prostacyclin are the most supported therapies for right ventricular failure, while treating the primary cause is preferred for PH secondary to critical illness.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zamanian et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: